Atossa Therapeutics (ATOS) Earnings Date & Reports
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology... Show more
ATOS is expected to report earnings to rise 20.00% to -5 cents per share on August 18
Q2'25
Est.
$-0.06
Q1'25
Beat
by $0.02
Q4'24
Beat
by $0.02
Q3'24
Est.
$-0.06
Q2'24
Beat
by $0.01
The last earnings report on May 13 showed earnings per share of -5 cents, beating the estimate of -7 cents. With 573.41K shares outstanding, the current market capitalization sits at 121.69M.